Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Feb 06, 8:10 AMBrightView (BV) held its Q1 2026 earnings call, and JPMorgan today raised its price target to $13 from $12 while reiterating an Underweight rating.

Peers: PLD CBRE BEKE AMH INVH FR PSA EQR AVB EXR

| Held by: VTI IWM VB VBR VXF IWN DFAT DFSV FNDA BSVO

Index	RUT	P/E	-	EPS (ttm)	-0.01	Insider Own	27.22%	Shs Outstand	94.50M	Perf Week	1.42%
Market Cap	1.28B	Forward P/E	16.07	EPS next Y	0.84	Insider Trans	-0.67%	Shs Float	68.55M	Perf Month	4.80%
Enterprise Value	2.63B	PEG	2.19	EPS next Q	0.10	Inst Own	80.05%	Short Float	3.67%	Perf Quarter	10.52%
Income	0.10M	P/S	0.47	EPS this Y	-2.92%	Inst Trans	-1.42%	Short Ratio	3.60	Perf Half Y	-11.61%
Sales	2.69B	P/B	1.02	EPS next Y	14.31%	ROA	1.55%	Short Interest	2.51M	Perf YTD	6.95%
Book/sh	13.27	P/C	34.50	EPS next 5Y	7.34%	ROE	2.90%	52W High	17.10 -20.78%	Perf Year	-15.84%
Cash/sh	0.39	P/FCF	74.21	EPS past 3/5Y	-2.39% -	ROIC	0.00%	52W Low	11.06 22.51%	Perf 3Y	66.26%
Dividend Est.	-	EV/EBITDA	7.87	Sales past 3/5Y	-1.24% 2.64%	Gross Margin	21.64%	Volatility	4.75% 2.76%	Perf 5Y	-6.62%
Dividend TTM	-	EV/Sales	0.98	EPS Y/Y TTM	-99.88%	Oper. Margin	5.65%	ATR (14)	0.41	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.26	Sales Y/Y TTM	-1.87%	Profit Margin	0.00%	RSI (14)	56.36	Recom	2.10
Dividend Gr. 3/5Y	- -	Current Ratio	1.26	EPS Q/Q	-25.42%	SMA20	2.38%	Beta	1.27	Target Price	16.28
Payout	0.00%	Debt/Eq	0.50	Sales Q/Q	2.59%	SMA50	4.69%	Rel Volume	1.57	Prev Close	12.92
Employees	18600	LT Debt/Eq	0.49	Earnings	Feb 03 AMC	SMA200	-4.04%	Avg Volume	697.73K	Price	13.55
IPO	Jun 28, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-154.35% 4.35%	Trades		Volume	1,097,203	Change	4.88%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-02-25	Initiated	BTIG Research	Buy	$15
Dec-02-24	Initiated	BTIG Research	Buy	$22
Nov-15-24	Upgrade	William Blair	Mkt Perform → Outperform
Aug-22-24	Initiated	Morgan Stanley	Equal-Weight	$16
Aug-21-24	Upgrade	Jefferies	Hold → Buy	$13 → $17
Jul-30-24	Upgrade	Robert W. Baird	Neutral → Outperform	$13 → $17
Jul-30-24	Initiated	Loop Capital	Buy	$18
Apr-04-24	Downgrade	Goldman	Neutral → Sell	$8 → $10
Mar-04-24	Initiated	Craig Hallum	Buy	$15
Nov-21-22	Downgrade	Jefferies	Buy → Hold	$14 → $8
Jan-10-22	Downgrade	William Blair	Outperform → Mkt Perform
Dec-20-21	Downgrade	Goldman	Buy → Neutral	$18 → $15
Oct-25-21	Downgrade	JP Morgan	Neutral → Underweight
Apr-15-21	Downgrade	Robert W. Baird	Outperform → Neutral	$16 → $19
Dec-03-20	Initiated	CJS Securities	Market Outperform	$22
Nov-27-19	Downgrade	Stifel	Buy → Hold	$19 → $17
Jul-18-19	Downgrade	JP Morgan	Overweight → Neutral	$18
Feb-13-19	Initiated	Berenberg	Buy	$20
Jul-23-18	Initiated	Stifel	Buy	$25
Jul-23-18	Initiated	Robert W. Baird	Outperform	$26

Show Previous Ratings

Feb-06-26 08:02AM	BrightView price target raised to $13 from $12 at JPMorgan (TipRanks)
Feb-05-26 12:07AM	BrightView Q1 Earnings Call Highlights (MarketBeat)
Feb-04-26 07:21PM	Why Brightview Holdings Stock Wilted on Wednesday (Motley Fool) -6.96%
04:02PM	BrightView Holdings Inc (BV) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com)
Feb-03-26 07:00PM	BrightView (BV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:10PM	Loading…
06:10PM	BrightView Holdings (BV) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:07PM	BrightView: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
05:06PM	BrightView's (NYSE:BV) Q4 CY2025 Sales Beat Estimates (StockStory)
04:10PM	BrightView Reports First Quarter Fiscal 2026 Results With Top-Line Revenue Growth & Improved Adjusted EBITDA; Reaffirms 2026 Guidance (Business Wire)
Feb-01-26 10:06PM	BrightView (BV) Q4 Earnings: What To Expect (StockStory)
Jan-14-26 04:15PM	BrightView Holdings, Inc. Announces First Quarter Fiscal Year 2026 Earnings Release Date, Conference Call and Webcast (Business Wire)
Dec-31-25 11:38PM	3 Low-Volatility Stocks with Questionable Fundamentals (StockStory)
Dec-16-25 11:05PM	3 Reasons to Avoid BV and 1 Stock to Buy Instead (StockStory)
Dec-11-25 04:15PM	BrightView Declares Eighth Consecutive Cash Dividend Payment on Preferred Stock (Business Wire)
Dec-10-25 04:15PM	BrightView to Participate in CJS Securities 2025 Virtual NDR (Business Wire)
12:34AM	Loading…
Nov-26-25 12:34AM	The 5 Most Interesting Analyst Questions From BrightView's Q3 Earnings Call (StockStory)
Nov-25-25 10:40PM	A Look Back at Environmental and Facilities Services Stocks' Q3 Earnings: BrightView (NYSE:BV) Vs The Rest Of The Pack (StockStory)
Nov-20-25 06:10PM	BV Q3 Deep Dive: Investments in Workforce and Fleet Aim to Reignite Growth (StockStory)
04:00PM	BrightView Holdings Inc (BV) Q4 2025 Earnings Call Highlights: Record EBITDA and Strategic ... (GuruFocus.com)
11:40AM	Why BrightView (BV) Shares Are Sliding Today (StockStory)
Nov-19-25 06:00PM	Here's What Key Metrics Tell Us About BrightView (BV) Q4 Earnings (Zacks)
05:25PM	BrightView Holdings (BV) Q4 Earnings and Revenues Lag Estimates (Zacks)
04:31PM	BrightView: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:27PM	BrightView (NYSE:BV) Misses Q3 CY2025 Sales Expectations, Stock Drops 16.7% (StockStory)
04:10PM	BrightView Posts Q4 and FY 2025 Earnings With Record Adjusted EBITDA; Projects Fiscal Year 2026 Revenue, Adjusted EBITDA, and Margin Growth; Increases Existing Share Repurchase Authorization (Business Wire)
Nov-17-25 10:01PM	BrightView (BV) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Nov-14-25 09:15AM	Stay Ahead of the Game With BrightView (BV) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Nov-12-25 07:45AM	Hydrofarm Holdings Group, Inc. (HYFM) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Nov-11-25 01:40PM	GrowGeneration Q3 Earnings Beat Estimates, Revenues Dip 6% Y/Y (Zacks)
Nov-06-25 06:50PM	GrowGeneration (GRWG) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
07:10AM	Loading…
Nov-05-25 07:10AM	Bunge Global (BG) Q3 Earnings Top Estimates (Zacks)
Oct-30-25 04:15PM	BrightView Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2025 Earnings Release Date, Conference Call and Webcast (Business Wire)
Oct-20-25 12:02AM	3 Reasons to Sell BV and 1 Stock to Buy Instead (StockStory)
Oct-01-25 06:15AM	BrightView Unites 19,000 Team Members with Pink Hats for Breast Cancer Awareness Month (Business Wire)
Sep-15-25 12:34AM	1 Stock Under $50 with Exciting Potential and 2 We Avoid (StockStory)
Sep-11-25 04:15PM	BrightView Declares Seventh Consecutive Cash Dividend Payment on Preferred Stock (Business Wire)
Aug-18-25 11:34PM	Winners And Losers Of Q2: BrightView (NYSE:BV) Vs The Rest Of The Environmental and Facilities Services Stocks (StockStory)
Aug-13-25 01:41AM	5 Insightful Analyst Questions From BrightView's Q2 Earnings Call (StockStory)
Aug-11-25 09:46AM	BV Q2 Deep Dive: Margin Expansion Amid Revenue Headwinds and Strategic Investments (StockStory)
Aug-06-25 08:00PM	BrightView (BV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -5.84%
07:10PM	BrightView Holdings (BV) Lags Q3 Earnings and Revenue Estimates (Zacks)
06:11PM	BrightView (NYSE:BV) Misses Q2 Sales Targets (StockStory)
06:08PM	BrightView: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	BrightView Posts Third Quarter Fiscal 2025 Earnings With Record Net Income and Adjusted EBITDA, and Reaffirms Full Year Guidance (Business Wire)
Aug-05-25 05:15PM	comScore (SCOR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
09:52AM	BrightView Holdings Inc (BV) Q3 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
Aug-04-25 11:22PM	BrightView (BV) Reports Earnings Tomorrow: What To Expect (StockStory)
05:45PM	Crawford & Company B (CRD.B) Q2 Earnings and Revenues Lag Estimates (Zacks)
Jul-31-25 05:50PM	Bright Horizons Family Solutions (BFAM) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
Jul-30-25 10:00AM	BrightView Holdings (BV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jul-29-25 06:30AM	From Racetrack to Ballpark: BrightView Builds MLB Field at Bristol (Business Wire)
12:03AM	BrightView (BV): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jul-18-25 12:40AM	3 Small-Cap Stocks with Questionable Fundamentals (StockStory)
Jul-17-25 08:45AM	5 Stocks Brokers Adore Even as Economic Uncertainty Lingers (Zacks)
Jul-16-25 04:15PM	BrightView Holdings, Inc. Announces Third Quarter Fiscal Year 2025 Earnings Release Date, Conference Call and Webcast (Business Wire)
Jul-15-25 08:26AM	Thomson Reuters (TRI) Moves 7.6% Higher: Will This Strength Last? (Zacks)
Jul-07-25 10:22AM	The 5 Most Interesting Analyst Questions From BrightView's Q1 Earnings Call (StockStory)
Jul-02-25 12:45PM	Why BrightView (BV) Shares Are Falling Today (StockStory) -10.09%
Jul-01-25 04:15PM	BrightView Updates Fiscal 2025 Financial Guidance (Business Wire)
Jun-12-25 04:15PM	BrightView Declares Cash Dividend Payment on Preferred Stock (Business Wire)
Jun-05-25 06:45AM	BrightView Announces Pricing of Upsized Secondary Offering (Business Wire)
Jun-04-25 11:31PM	Q1 Earnings Highs And Lows: BrightView (NYSE:BV) Vs The Rest Of The Environmental and Facilities Services Stocks (StockStory)
May-29-25 04:15PM	BrightView to Participate in Upcoming 2025 Investor Conferences (Business Wire)
May-09-25 03:19AM	BrightView Holdings Inc (BV) Q2 2025 Earnings Call Highlights: Record EBITDA and Strategic ... (GuruFocus.com)
12:35AM	3 Stocks Under $50 Walking a Fine Line (StockStory)
May-07-25 08:00PM	BrightView (BV) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) +8.46%
07:25PM	BrightView Holdings (BV) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
06:16PM	BrightView: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:10PM	BrightView Posts Second Quarter Fiscal 2025 Earnings With Record Adjusted EBITDA and Raises Full Year Guidance (Business Wire)
10:14AM	Earnings To Watch: BrightView Holdings Inc (BV) Reports Q2 2025 Results (GuruFocus.com)
May-06-25 07:40AM	Aramark (ARMK) Beats Q2 Earnings Estimates (Zacks)
May-01-25 04:15PM	BrightView to Participate in Upcoming Spring 2025 Investor Conferences (Business Wire)
07:40AM	Thomson Reuters (TRI) Surpasses Q1 Earnings Estimates (Zacks)
Apr-28-25 09:06AM	2 Profitable Stocks on Our Buy List and 1 to Think Twice About (StockStory)
Apr-22-25 04:15PM	BrightView Holdings, Inc. Announces Second Quarter Fiscal Year 2025 Earnings Release Date, Conference Call and Webcast (Business Wire)
Apr-07-25 05:09AM	Unpacking Q4 Earnings: BrightView (NYSE:BV) In The Context Of Other Environmental and Facilities Services Stocks (StockStory)
Mar-28-25 05:14AM	BrightView (BV): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Mar-21-25 12:25PM	BrightView Can Meander Before Taking Off (SeekingAlpha)
Mar-13-25 04:20PM	BrightView Announces $100 Million Share Repurchase Program (Business Wire)
Mar-12-25 04:15PM	BrightView Declares Fifth Consecutive Cash Dividend Payment on Preferred Stock (Business Wire)
Feb-27-25 04:10PM	BrightView to Participate in Loop Capital Markets 2025 Investor Conference (Business Wire)
Feb-11-25 08:09AM	Rollins Earnings: What To Look For From ROL (StockStory)
Feb-07-25 02:12AM	BrightView Holdings Inc (BV) Q1 2025 Earnings Call Highlights: Strong Growth Amidst Market ... (GuruFocus.com)
Feb-05-25 07:00PM	Compared to Estimates, BrightView (BV) Q1 Earnings: A Look at Key Metrics (Zacks) -6.58%
06:10PM	BrightView Holdings (BV) Q1 Earnings Meet Estimates (Zacks)
05:19PM	BrightView (NYSE:BV) Misses Q4 Revenue Estimates (StockStory)
05:13PM	BrightView: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:10PM	BrightView Reports First Quarter Fiscal 2025 Results, Expanded Margins, Reaffirms 2025 Guidance (Business Wire)
07:10AM	BrightView Holdings Inc (BV) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-04-25 08:08AM	BrightView (BV) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
07:11AM	What To Expect From BrightView Holdings Inc (BV) Q1 2025 Earnings (GuruFocus.com)
Feb-03-25 04:15PM	Registration is Open for BrightViews Investor Day (Business Wire)
Jan-29-25 04:15PM	BrightView Announces Successful Term Loan Repricing (Business Wire)
Jan-21-25 04:15PM	BrightView Holdings, Inc. Announces First Quarter Fiscal Year 2025 Earnings Release Date, Conference Call and Webcast (Business Wire)
Jan-14-25 04:04AM	Environmental and Facilities Services Stocks Q3 In Review: BrightView (NYSE:BV) Vs Peers (StockStory) +5.43%
Jan-07-25 04:15PM	BrightView to Participate in Upcoming CJS Securities 25th Annual New Ideas for the New Year Conference (Business Wire)
Jan-01-25 04:07AM	Three Reasons to Avoid BV and One Stock to Buy Instead (StockStory)
Dec-31-24 04:02AM	Q3 Rundown: Rollins (NYSE:ROL) Vs Other Environmental and Facilities Services Stocks (StockStory)
Dec-17-24 04:15PM	BrightView Declares Cash Dividend Payment on Preferred Stock (Business Wire)
Nov-22-24 06:30AM	BrightView to Host Investor Day (Business Wire)

BrightView Holdings, Inc. is an investment company, which engages in the provision of commercial landscaping services. It operates through the Maintenance Services and Development Services segments. The Maintenance Services segment focuses on recurring landscape maintenance services, snow removal services, and supplemental landscape enhancement services. The Development Services segment offers landscape architecture and development services for new construction and large scale redesign projects. The company was founded on November 7, 2013 and is headquartered in Blue Bell, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Cornog William L	Director	Dec 02 '25	Buy	12.84	10,000	128,400	30,000	Dec 03 05:00 PM
Gottsegen Jonathan Mark	EVP, CLO & Corporate Secretary	Dec 01 '25	Sale	12.62	35,000	441,700	142,958	Dec 03 05:00 PM
Gottsegen Jonathan Mark	Officer	Dec 01 '25	Proposed Sale	12.62	35,000	441,548		Dec 01 12:07 PM
Urban Brett Nicholas	Chief Financial Officer	Aug 26 '25	Sale	14.54	62,619	910,480	14,212	Aug 27 05:00 PM
Urban Brett Nicholas	Chief Financial Officer	Aug 25 '25	Sale	14.66	14,800	216,968	76,831	Aug 27 05:00 PM
Orders Amanda Marie	EVP & CHRO	Aug 25 '25	Sale	14.78	70,000	1,034,600	38,446	Aug 27 05:00 PM
BRETT N URBAN	Officer	Aug 26 '25	Proposed Sale	14.57	62,619	912,096		Aug 26 04:04 PM
Orders Amanda Marie	Officer	Aug 25 '25	Proposed Sale	14.78	70,000	1,034,306		Aug 25 04:30 PM
BRETT N URBAN	Officer	Aug 25 '25	Proposed Sale	14.73	14,800	218,005		Aug 25 04:21 PM
KKR Group Partnership L.P.	10% Owner	Jun 06 '25	Sale	14.40	11,600,000	167,040,000	21,533,123	Jun 10 04:30 PM
KKR BrightView Aggregator L.P.	10% Owner	Jun 06 '25	Sale	14.40	11,600,000	167,040,000	21,533,123	Jun 10 04:30 PM
Barker Kurtis T	Director	Mar 14 '25	Buy	13.25	40,000	530,044	40,000	Mar 18 05:15 PM
Cornog William L	Director	Feb 21 '25	Buy	13.49	10,000	134,950	20,000	Feb 21 04:30 PM

Open in Screener

AZTA

Azenta Inc

Feb 06 • 04:00PM ET

28.72

+0.87 3.12 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: DHR ILMN TMO A BIO HOLX WAT CTLT QGEN MMS

| Held by: IJR VTI VB IWM VBR VXF SPSM IWN VTWO DFSV

Index	RUT	P/E	-	EPS (ttm)	-1.27	Insider Own	1.04%	Shs Outstand	46.02M	Perf Week	-26.13%
Market Cap	1.32B	Forward P/E	28.24	EPS next Y	1.02	Insider Trans	0.46%	Shs Float	45.51M	Perf Month	-23.43%
Enterprise Value	963.23M	PEG	0.81	EPS next Q	0.12	Inst Own	113.21%	Short Float	8.92%	Perf Quarter	-5.96%
Income	-57.82M	P/S	2.22	EPS this Y	52.70%	Inst Trans	-3.60%	Short Ratio	5.57	Perf Half Y	-1.41%
Sales	595.19M	P/B	0.77	EPS next Y	30.61%	ROA	1.41%	Short Interest	4.06M	Perf YTD	-13.65%
Book/sh	37.26	P/C	3.21	EPS next 5Y	34.65%	ROE	1.69%	52W High	55.63 -48.38%	Perf Year	-46.58%
Cash/sh	8.96	P/FCF	42.70	EPS past 3/5Y	40.29% -	ROIC	-3.27%	52W Low	23.91 20.12%	Perf 3Y	-50.63%
Dividend Est.	-	EV/EBITDA	19.65	Sales past 3/5Y	2.25% 8.85%	Gross Margin	45.30%	Volatility	9.39% 4.77%	Perf 5Y	-64.03%
Dividend TTM	-	EV/Sales	1.62	EPS Y/Y TTM	57.71%	Oper. Margin	-1.30%	ATR (14)	2.06	Perf 10Y	201.36%
Dividend Ex-Date	Dec 02, 2021	Quick Ratio	2.61	Sales Y/Y TTM	-8.36%	Profit Margin	-9.71%	RSI (14)	24.70	Recom	2.12
Dividend Gr. 3/5Y	- -	Current Ratio	2.92	EPS Q/Q	-14.91%	SMA20	-23.49%	Beta	1.40	Target Price	38.71
Payout	-	Debt/Eq	0.03	Sales Q/Q	0.77%	SMA50	-20.71%	Rel Volume	1.29	Prev Close	27.85
Employees	3000	LT Debt/Eq	0.03	Earnings	Feb 04 BMO	SMA200	-9.25%	Avg Volume	728.65K	Price	28.72
IPO	Feb 02, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	-34.83% 1.06%	Trades		Volume	939,287	Change	3.12%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-05-26	Upgrade	Evercore ISI	In-line → Outperform	$50
Dec-19-25	Reiterated	Needham	Buy	$42 → $44
Oct-30-25	Upgrade	Jefferies	Hold → Buy	$38
Aug-06-25	Upgrade	Raymond James	Mkt Perform → Outperform	$35
Jul-22-25	Resumed	Stephens	Equal-Weight	$35
Dec-18-24	Upgrade	Stephens	Equal-Weight → Overweight	$50 → $60
Apr-04-24	Initiated	Jefferies	Hold	$64
Feb-01-24	Reiterated	B. Riley Securities	Buy	$61 → $79
Jul-19-23	Initiated	Raymond James	Mkt Perform
May-10-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Feb-09-23	Downgrade	Stephens	Overweight → Equal-Weight	$65 → $60
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line	$60 → $62
Mar-31-22	Resumed	B. Riley Securities	Buy	$106
Mar-21-22	Initiated	Evercore ISI	Outperform	$100

Show Previous Ratings

Feb-05-26 08:00AM	Stocks making big moves yesterday: Azenta, FTAI Aviation, Reddit, Columbia Sportswear, and RenaissanceRe (StockStory)
12:33AM	AZTA Q4 Deep Dive: Operational Challenges and Turnaround Efforts Dominate Results (StockStory)
Feb-04-26 04:03PM	Azenta Inc (AZTA) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Focus ... (GuruFocus.com) -22.81%
12:25PM	Azenta (AZTA) Stock Trades Down, Here Is Why (StockStory)
10:10AM	Azenta Q1 Earnings Call Highlights (MarketBeat)
09:59AM	Loading…
09:59AM	Azenta (AZTA) Q1 2026 Earnings Call Transcript (Motley Fool)
08:12AM	Azenta's (NASDAQ:AZTA) Q4 CY2025: Beats On Revenue (StockStory)
06:30AM	Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025 (PR Newswire)
Feb-02-26 10:17PM	Azenta (AZTA) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Jan-21-26 04:05PM	Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast (PR Newswire)
Jan-08-26 04:48AM	New Strong Sell Stocks for January 8th (Zacks)
Jan-05-26 03:45PM	Why Are Azenta (AZTA) Shares Soaring Today (StockStory) +7.07%
Dec-31-25 09:01AM	Vale and Azenta have been highlighted as Zacks Bull and Bear of the Day (Zacks)
04:00AM	Bear of the Day: Azenta (AZTA) (Zacks)
Dec-30-25 08:05AM	Azenta enters agreement for sale of B Medical Systems to THELEMA for $63M (TipRanks)
03:12AM	Loading…
03:12AM	New Strong Sell Stocks for December 30th (Zacks)
Dec-29-25 08:00AM	Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.A R.L. (PR Newswire)
Dec-28-25 11:02PM	Azenta (AZTA): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Dec-15-25 05:46AM	New Strong Sell Stocks for Dec. 15 (Zacks)
Dec-10-25 12:43PM	Azenta Authorizes $250 Million Share Repurchase Program (PR Newswire)
Dec-09-25 05:51AM	New Strong Sell Stocks for December 9th (Zacks)
Dec-02-25 11:32PM	3 Healthcare Stocks We're Skeptical Of (StockStory)
Nov-27-25 10:32PM	Q3 Rundown: Azenta (NASDAQ:AZTA) Vs Other Drug Development Inputs & Services Stocks (StockStory)
Nov-24-25 01:01PM	Why Azenta (AZTA) Stock Is Trading Up Today (StockStory) +5.19%
Nov-22-25 12:30AM	AZTA Q3 Deep Dive: Operational Discipline and Product Strength Support Margin Expansion (StockStory)
Nov-21-25 05:16PM	Why Azenta (AZTA) Stock Is Up Today (StockStory) +16.30% +5.19%
04:00PM	Azenta Inc (AZTA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
06:41AM	Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales (StockStory)
06:30AM	Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025 (PR Newswire)
Nov-19-25 10:01PM	Azenta (AZTA) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
04:05PM	Loading…
Nov-12-25 04:05PM	Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast (PR Newswire)
Nov-10-25 05:20PM	Outset Medical, Inc. (OM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-06-25 06:05PM	TruBridge (TBRG) Q3 Earnings and Revenues Surpass Estimates (Zacks)
Nov-05-25 07:05PM	Senseonics Holdings (SENS) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Nov-04-25 04:05PM	Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer (PR Newswire)
Oct-15-25 08:00AM	Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana (PR Newswire)
Sep-09-25 08:44AM	TEM Q2 Revenues Soar Amid Coverage Issues: Time to Buy, Hold or Sell? (Zacks)
Sep-02-25 08:04AM	Here's What Pressured Azenta (AZTA) in Q2 (Insider Monkey)
Aug-25-25 11:36PM	Spotting Winners: Azenta (NASDAQ:AZTA) And Drug Development Inputs & Services Stocks In Q2 (StockStory)
Aug-21-25 12:02AM	3 Reasons to Avoid AZTA and 1 Stock to Buy Instead (StockStory)
Aug-13-25 05:50PM	Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know (StockStory) +9.83%
12:13AM	The Top 5 Analyst Questions From Azenta's Q2 Earnings Call (StockStory)
12:11AM	AZTA Q2 Deep Dive: Product Mix Shifts and Cost Controls Define Flat Quarter (StockStory)
Aug-07-25 03:36PM	Why Azenta (AZTA) Stock Is Up Today (StockStory)
Aug-06-25 02:50PM	Azenta (AZTA) Stock Trades Up, Here Is Why (StockStory) +5.58%
Aug-05-25 12:40PM	Why Azenta (AZTA) Stock Is Trading Lower Today (StockStory) -17.00%
07:16AM	Azenta (NASDAQ:AZTA) Misses Q2 Sales Targets (StockStory)
06:30AM	Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance (PR Newswire)
Aug-03-25 11:10PM	Azenta (AZTA) Q2 Earnings Report Preview: What To Look For (StockStory)
Jul-31-25 04:05PM	Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology (PR Newswire)
08:30AM	Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care (PR Newswire)
Jul-30-25 04:05PM	Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
Jul-23-25 04:05PM	Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jul-22-25 02:06PM	Why Azenta (AZTA) Stock Is Up Today (StockStory) +5.11%
Jul-17-25 11:31PM	Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jul-16-25 11:33PM	Q1 Earnings Outperformers: Azenta (NASDAQ:AZTA) And The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jun-02-25 12:02AM	3 Reasons to Sell AZTA and 1 Stock to Buy Instead (StockStory)
May-13-25 04:05PM	Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development (PR Newswire)
May-08-25 03:11AM	Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic ... (GuruFocus.com) +9.70%
May-07-25 01:45PM	Azenta targets 3%-5% organic growth and expands automation initiatives for FY2025 (Seeking Alpha)
01:44PM	Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript (Seeking Alpha)
09:35AM	Netflix Investors Unfazed by Tariffs With Growth Engine Humming (Bloomberg)
06:30AM	Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 (PR Newswire)
Apr-29-25 09:01AM	2 Cash-Heavy Stocks Worth Your Attention and 1 to Approach with Caution (StockStory)
Apr-24-25 04:15PM	Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast (PR Newswire) +5.16%
Apr-17-25 09:31AM	Azenta: Life Science Business Failing To Come To Life (Seeking Alpha)
Mar-27-25 05:13AM	3 Reasons AZTA is Risky and 1 Stock to Buy Instead (StockStory)
Mar-24-25 04:05PM	Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report (PR Newswire)
Mar-10-25 05:05PM	Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum (PR Newswire) -6.62%
Feb-05-25 08:23AM	Azentas (NASDAQ:AZTA) Q4 Sales Top Estimates (StockStory)
07:00AM	Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024 (PR Newswire)
Feb-04-25 03:59PM	Is Azenta (AZTA) the Mid-Cap Stock Insiders Are Buying Recently? (Insider Monkey)
Jan-30-25 04:05PM	Azenta Announces the Election of Dipal Doshi to its Board of Directors (PR Newswire)
Jan-27-25 04:05PM	Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Jan-23-25 04:05PM	UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence (PR Newswire)
Nov-29-24 01:00AM	Azenta, Inc. Navigates Global Data Protection Laws Amid Business Risks (TipRanks)
Nov-19-24 05:56PM	Flex Set to Join SandP MidCap 400; Azenta and Concentra Group Holdings to Join SandP SmallCap 600 (PR Newswire) +9.14%
05:56PM	Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 (PR Newswire)
Nov-14-24 08:00AM	Azenta to Participate in Stephens Annual Investment Conference (PR Newswire)
Nov-13-24 02:17AM	Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ... (GuruFocus.com)
Nov-12-24 04:05PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO (PR Newswire)
Nov-04-24 04:05PM	Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire) +8.93%
08:00AM	Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value (PR Newswire)
Oct-30-24 04:05PM	Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test (PR Newswire)
Sep-04-24 08:00AM	AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO (PR Newswire)
Aug-12-24 04:05PM	GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event (PR Newswire)
Aug-06-24 04:05PM	Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024 (PR Newswire) -8.93%
Aug-05-24 04:05PM	Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
Jul-24-24 04:05PM	Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jul-22-24 04:05PM	FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study (PR Newswire) +8.10%
Jun-04-24 04:05PM	Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research (PR Newswire)
May-23-24 04:05PM	Azenta to Participate in the Jefferies Global Healthcare Conference (PR Newswire)
May-14-24 06:34AM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Robotics Stocks (InvestorPlace)
May-13-24 04:46PM	Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK (PR Newswire)
May-10-24 01:07PM	Azenta Inc (AZTA) Q2 Fiscal 2024 Earnings: Revenue Growth Amid Challenges (GuruFocus.com)
May-09-24 12:53PM	Azenta, Inc. (NASDAQ:AZTA) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 08:58PM	AZTA Stock Earnings: Azenta Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
04:06PM	Azenta Announces CEO Succession Plan (PR Newswire)
04:05PM	Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024 (PR Newswire)
May-01-24 04:05PM	Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast (PR Newswire)

Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Marotta John	President and CEO	Sep 10 '25	Sale	29.41	316	9,294	105,980	Sep 12 04:10 PM
Lin Lawrence Y.	EVP, CFO and Treasurer	Aug 11 '25	Buy	27.96	2,500	69,900	46,013	Aug 12 04:05 PM

BV

BrightView Holdings Inc

AZTA

Azenta Inc

Upgrade your FINVIZ experience